These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1500664

  • 1. Pathogenesis of hepatic fibrosis and the role of cytokines.
    Lissoos TW, Davis BH.
    J Clin Gastroenterol; 1992 Jul; 15(1):63-7. PubMed ID: 1500664
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P, Yee HF.
    Eur J Surg Suppl; 2002 Jul; (587):100-12. PubMed ID: 16144208
    [Abstract] [Full Text] [Related]

  • 4. Hepatic stellate cells and liver fibrosis.
    Moreira RK.
    Arch Pathol Lab Med; 2007 Nov; 131(11):1728-34. PubMed ID: 17979495
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of fetuin, a TGFbeta antagonist and pentoxifylline, a cytokine antagonist on hepatic stellate cell function and fibrotic parameters in fibrosis.
    Verma-Gandhu M, Peterson MR, Peterson TC.
    Eur J Pharmacol; 2007 Oct 31; 572(2-3):220-7. PubMed ID: 17678645
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis.
    Zhu J, Wu J, Frizell E, Liu SL, Bashey R, Rubin R, Norton P, Zern MA.
    Gastroenterology; 1999 Nov 31; 117(5):1198-204. PubMed ID: 10535884
    [Abstract] [Full Text] [Related]

  • 10. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM.
    Z Gastroenterol; 1992 Mar 31; 30 Suppl 1():5-16. PubMed ID: 1449018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Liver fibrogenesis and cytokines].
    Okuno M, Moriwaki H.
    Nihon Shokakibyo Gakkai Zasshi; 1998 Jul 31; 95(7):743-9. PubMed ID: 9721514
    [No Abstract] [Full Text] [Related]

  • 14. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy.
    Li D, Friedman SL.
    J Gastroenterol Hepatol; 1999 Jul 31; 14(7):618-33. PubMed ID: 10440206
    [Abstract] [Full Text] [Related]

  • 15. TGF beta1 and PDGF AA override collagen type I inhibition of proliferation in human liver connective tissue cells.
    Geremias AT, Carvalho MA, Borojevic R, Monteiro AN.
    BMC Gastroenterol; 2004 Dec 03; 4():30. PubMed ID: 15579200
    [Abstract] [Full Text] [Related]

  • 16. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis].
    Casu A, Canepa M, Nanni G.
    Pathologica; 1994 Oct 03; 86(5):467-99. PubMed ID: 7739873
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutical targets for revert liver fibrosis].
    García B L, Gálvez G J, Armendáriz B J.
    Rev Med Chil; 2007 Jun 03; 135(6):783-91. PubMed ID: 17728907
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
    Zhou B, Ling L, Zhang F, Liu TY, Zhou H, Qi XH, Chen Q, Li YH, Kang YM, Zhu GQ.
    Cell Physiol Biochem; 2018 Jun 03; 48(1):227-236. PubMed ID: 30007970
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.